Healthcare Technologies-themed Zoomposium: 20 September 2022

Published: 1 September 2022

Dr Donata IANDOLO: ‘Bioelectronics: an innovative approach to communicate with biology’ Dr Stephen LINDSAY: 'What does participation mean in digital healthcare design?’ Dr Affar KARIMULLAH: ‘Application of Plasmonics, Metamaterials and Photonics for sensing and spectroscopy’

Watch the Zoomposium here (Passcode: Xi8D@2g*)


Dr Donata Iandolo, James Watt School of Engineering

Bioelectronics: an innovative approach to communicate with biology’ 

My main focus is the use of bioelectronics materials and devices to study and stimulate stem and immune cells for both in vitro and in vivo applications. My main interest is deciphering the bioelectric code of cell differentiation and commitment towards specific cell types. First step will be building up an in vitro model to host and monitor both cell types. Bioelectronics, conducting polymers, OECT, stem cell, SEM, electrochemistry. I seek collaborations with people with expertise in sensing at large, device fabrication, microfluidics, physical stimulation, simulation of electric field-material interaction, immunology, bone tissue engineering. I am planning on submitting grants on integration of in vitro 3D system with sensing platforms for biomedical applications.


Dr Stephen Lindsay, School of Computing Science

What does participation mean in digital healthcare design?

I try to understand how, why, and when we should talk with people living with healthcare challenges about the design of digital technologies to serve their needs. This leads to asking questions about what they value, whether they want a service to become digital, and how we can exploit their existing practices with digital technology. Participatory design in this area needs to balance complex power relationships between carers, healthcare professionals, and patients; push innovative designs that add value beyond basic benefits like stakeholder buy-in to ideas; and account for differing needs in design because, for example, stakeholders might live with intellectual disabilities. Increasingly, I’ve focused on how we can open the act of making technology in healthcare to excluded groups of people to understand what they do differently.


Dr Affar Karimullah, School of Chemistry

Application of Plasmonics, Metamaterials and Photonics for sensing and spectroscopy.

I will present a short brief about how my group is using plasmonics to develop applications in biosensing and surface enhanced Raman spectroscopy for sensing of specific diseases and chemical moieties that are aimed to provide solutions for industrial and healthcare markets. I seek collaborations with academics interested in biochemical research, applying label-free point of care for real world applications, chiral molecule detection. I have an interest in funding applications related to: commercial and academic applications of our biosensor platform,  applications of our SERS substrates for chiral enantiomer recognition.





First published: 1 September 2022